​

Funding Round

Series C - Evariant

Series C - Evariant

Investment Firm

Overview

Evariant enables providers to optimize growth through smarter patient acquisition and retention.

Announced Date

Nov 23, 2015

Funding Type

Series C

Highlights

Location

United States, North America

Social

Investor Lead

Goldman Sachs

Goldman Sachs

Goldman Sachs is a debt and early_stage_venture and late_stage_venture and private_equity and seed firm.

Participant Investors

5

Investor Name
Participant InvestorDignity Health
Participant InvestorHealth Enterprise Partners
Participant InvestorLightspeed Venture Partners
Participant InvestorGoldman Sachs
Participant InvestorSalesforce

Round Details and Background

Evariant raised $42335167 on 2015-11-23 in Series C

Evariant enables providers to optimize growth through smarter patient acquisition and retention.

Company Funding History

7

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
May 02, 2014
Series B - Evariant
2-18.3M
Feb 27, 2014
Debt Financing - Evariant
-1.5M
Jun 01, 2012
Venture Round - Evariant
-2.6M
Nov 21, 2011
Series A - Evariant
1-5.3M

Recent Activity

There is no recent news or activity for this profile.